Dewpoint Therapeutics Europe

Dewpoint Therapeutics Europe is owned by Dewpoint Therapeutics. Dewpoint Therapeutics has a direct presence in 2 countries.

View the org chart displaying its 2 main executives

Most searched biographies at Dewpoint Therapeutics Europe

• Marc Hentz, Managing Director
• Mandy Obst, Senior Lab Manager

Create your alert
to follow the executive moves at Dewpoint Therapeutics Europe.

Dewpoint Therapeutics has 2,276 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Histogen has filed for bankruptcy protection  (posted on April 19 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on April 18 2024).
• Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences  (posted on April 16 2024).

Popular contacts in Biotechnology

• Vik Bajaj - Director at Interline Therapeutics
• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Dewpoint Therapeutics Europe

Social media about Dewpoint Therapeutics Europe

• Dewpoint Therapeutics Europe on Wikipedia, Google News & Yahoo Finance
• Dewpoint Therapeutics Europe on LinkedIn, Twitter & YouTube

Contact by email its executives including Marc Hentz

Call Dewpoint Therapeutics Europe at +49 351 ...

View the org chart

Register to receive your alert

Report an error